Labcorp stock holds near its yearly high
Published on 09/01/2026 at 18:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp stock (ISIN US50540R4092) traded at USD 333.61 on September 1, 2026, down 0.45 percent on the day, with a market capitalization of USD 27.06 billion and a 52-week range of USD 244.52 to USD 341.80. The stock closed its latest snapshot just below the top of that band, which keeps valuation in sharp view for investors.
Guidance sets the tone
According to MarketBeat, the companys key stats also show a volume of 851,135 shares and a consensus rating of Moderate Buy on September 1, 2026. The same snapshot lists a price target of USD 330.00, slightly below the last price, which makes the current trading level more important than the target narrative.
Labcorp has also been framed by 2026 guidance of USD 18.10 to USD 18.55 in EPS, against a consensus estimate of USD 18.32 per share. That leaves the midpoint at USD 18.325, only a few cents above consensus and a useful sign that expectations are already tight.
2026 earnings power
The most recent reported figures in the market data set point to a quarterly dividend of USD 0.72 and a P/E ratio of 27.59 on September 1, 2026. With shares near the 52-week high and the market cap above USD 27 billion, the focus stays on whether 2026 earnings can justify that multiple.
For investors, the comparison is straightforward: a stock at USD 333.61 versus a 52-week high of USD 341.80 leaves only USD 8.19 of upside to the top of the range. That is a narrow gap for a company whose guidance band still spans USD 0.45 per share.
Labcorp diagnostics focus
Labcorp, formally Laboratory Corporation of America Holdings, operates in clinical laboratory and drug development services, so the revenue mix is tied to recurring testing demand and outsourced research work. The market data page describes it as a global life sciences company, which matches the way the stock is being priced as a defensive growth name.
The same profile shows Labcorp stock on the NYSE under the ticker LH, with the latest snapshot taken on September 1, 2026. That combination of a high-teens earnings outlook, a USD 27.06 billion market value and a price close to the yearly peak is the clearest read-through from the current tape.
Stock near the top
Labcorp stock stood at USD 333.61 as of September 1, 2026, with intraday trading between USD 329.64 and USD 335.84. The price remained below the 52-week high of USD 341.80, but close enough to keep the chart firmly in the upper range.
Labcorp at a glance
- Company: Laboratory Corporation of America Holdings
- ISIN: US50540R4092
- Ticker: LH
- Trading venue: NYSE
- Price (as of September 1, 2026): USD 333.61
- Market capitalization: USD 27.06 billion
- Sector / Industry: Health Care / Life Sciences Tools and Services
- Index membership: S&P 500
